Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386892 · ClinicalTrials.gov registry record
Immunological Characterization of Blood of Normal Individuals
A clinical trial of Heathly Volunteers, sponsored by Ohio State University.
- Completed
- Registry status
- 1,300
- Enrollment target
- 1
- Study location
NCT01386892: Completed study of Heathly Volunteers, sponsored by Ohio State University.
NCT01386892 is a study of Heathly Volunteers that has completed, run by Ohio State University. The registered enrollment target is 1,300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01386892, a study of Heathly Volunteers, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to obtain normal samples of blood, saliva and urine to serve as controls for other approved protocols and for analysis. These include determination of the functional capabilities of cells, proteins, nucleic acids and microvesicles obtained from peripheral blood including plasma, serum and cellular fraction from normal individuals. Saliva and urine will have similar testing which may also be compared to the blood testing results. The ongoing objective varies from investigation to investigation but in general the investigational goals are to better understand the immune function of normal volunteers and compare it to immune function in disease states.
Primary Outcome
Test for differences in the blood of individuals with lung disease and normal healthy controls.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2011-03-01 |
| Est. Completion | 2015-01-05 |
What the finished NCT01386892 record still lists
NCT01386892 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Heathly Volunteers appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT01386892 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01386892 about?
NCT01386892 is a clinical study titled "Immunological Characterization of Blood of Normal Individuals". This study seeks to obtain normal samples of blood, saliva and urine to serve as controls for other approved protocols and for analysis. These include determination of the functional capabilities of cells, proteins, nucleic acids and microvesicles obtained from peripheral blood including plasma, ser...
What is the current status of trial NCT01386892?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2011-03-01. Estimated completion is 2015-01-05.
What conditions does trial NCT01386892 study?
This clinical trial studies the following conditions: Heathly Volunteers.
What interventions are being tested in trial NCT01386892?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01386892?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386892 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI